Where does Five3 Genomics, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Five3 Genomics, LLC ranks #26,305 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Five3 Genomics, LLC hold?

Five3 Genomics, LLC holds 10 US utility patents granted between 2019 and 2025, spanning 7 technology areas.

What is Five3 Genomics, LLC's Innovation Score?

Five3 Genomics, LLC has an Innovation Score of 27.1 out of 100 (22nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Five3 Genomics, LLC's patent grant rate increasing or decreasing?

Five3 Genomics, LLC's recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Five3 Genomics, LLC's patents?

Five3 Genomics, LLC's patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Five3 Genomics, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Five3 Genomics, LLC

Q: What technology areas does Five3 Genomics, LLC focus on?

Five3 Genomics, LLC's top technology area is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology) with 10 patents, ranking #70 of 676 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 7 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Five3 ranks #26,305 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 7 technology areas.

#26,305
of 49,997 US assignees by volume: 22nd percentile
by Innovation Score (27.1/100): 14.3
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26305 · US Corporation #26,305 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,305/49,997
PHOTO-FINISH First Ammonia Motors
CPC-NARROW G16B · 7 areas
INNOV-THIN 27.1/100
CLAIMS-RICH 14.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: First Ammonia Motors, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Five3’s 27.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (31%) Velocity 0.8 pts (3%) Breadth 9.4 pts (35%) Claim depth 8.6 pts (32%)

Qualcomm Incorporated · highest

85
Five3 Genomics · this assignee

27
3D Lighting… · lowest

7

What this shows Five3's Innovation Score is 27.1/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Five3?

Each dot is one of Five3’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Five3’s own 14.3 claims/patent is at or below the 14.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Five3 vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Five3's grants concentrate

Five3 Genomics, LLC is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2022. By volume, Five3 sits between First Ammonia Motors, Inc. and Flow-Rite Controls, Ltd..

Five3's three-year grant acceleration

Five3 Genomics, LLC shows 1 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

First Ammonia Mot…

10
Firstbeat Analyti…

10
Firstbeat Oy

10
Fischer Block

10
Flirtey Holdings

10
Flo-tech

10
Floratine Product…

10
Flow-rite Controls

10
Five3 Genomics ◀

10

What this shows Five3 holds 10 patents at rank #26,323, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Five3

By rank, the assignees closest to #26,323 in granted patent volume.

Leaders in G16B (Bioinformatics)

Other assignees with the most granted patents in Five3's primary technology class.

Five3's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Five3 Genomics, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	3	30.0%
2020	3	30.0%
2021	2	20.0%
2022	1	10.0%
2025partial year	1	10.0%

Which technologies does Five3 Genomics, LLC patent most?

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 10

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

G09G - Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information 1

G06T - Image Data Processing OR Generation, IN General 1

G06F - Electric Digital Data Processing 1

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Five3 Genomics, LLC's patent record in context - here's where to go next.

Five3 Genomics, LLC's lead technology class is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology), 100% of its portfolio - see every assignee active in that class. Explore G16B
Ranked #26,305 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Five3 Genomics, LLC against First Ammonia Motors, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.